Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
2450 Riverside Ave Se, East Building Journey Clinic 9e, 
Minneapolis, MN 

Overview

Emily Greengard is a Pediatric Hematologist Oncology provider in Minneapolis, Minnesota. Dr. Greengard is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Osteosarcoma, Neuroblastoma, Adult Soft Tissue Sarcoma, Embryonal Tumor with Multilayered Rosettes, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 15 peer reviewed articles and participating in 61 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 3 clinical trials in the study of Diffuse Midline Glioma H3 K27M-Mutant.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in PA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 6 Less Insurance Carriers -

Locations

2450 Riverside Ave Se, East Building Journey Clinic 9e, Minneapolis, MN 55454

Additional Areas of Focus

Dr. Greengard has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


59 Clinical Trials

A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Renal Tumors Classification, Biology, and Banking Study
View 44 Less Clinical Trials
Similar Doctors
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology
420 Delaware St Se, Mmc 366, 
Minneapolis, MN 
 (0.4 miles away)
Languages Spoken:
English

Brenda Weigel is a Pediatric Hematologist Oncology provider in Minneapolis, Minnesota. Dr. Weigel is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Infantile Neutropenia, and Osteosarcoma.

Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology

Fairview Express Care

2450 Riverside Ave, 
Minneapolis, MN 
 (0.1 miles away)
Languages Spoken:
English

Christopher Moertel is a Pediatric Hematologist Oncology provider in Minneapolis, Minnesota. Dr. Moertel is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, and RASopathies.

Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology
2530 Chicago Ave, Children's Specialty Center Suite 175, 
Minneapolis, MN 
 (1.5 miles away)
Languages Spoken:
English

Mary Skrypek is a Pediatric Hematologist Oncology provider in Minneapolis, Minnesota. Dr. Skrypek is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Glioma, Pineocytoma, Medulloblastoma, and Embryonal Tumor with Multilayered Rosettes.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Greengard's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile